AA
AlphaCentric Advisors Portfolio holdings
AUM
$100M
This Quarter Return
-5.2%
1 Year Return
+18.84%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$176M
AUM Growth
+$176M
(-2.2%)
Cap. Flow
+$6.06M
Cap. Flow
% of AUM
3.44%
Top 10 Holdings %
Top 10 Hldgs %
22.12%
Holding
256
New
24
Increased
39
Reduced
132
Closed
21
Top Buys
| 1 |
WBA
Walgreens Boots Alliance
WBA
|
$3.22M |
| 2 |
uniQure
QURE
|
$2.31M |
| 3 |
RVNC
Revance Therapeutics, Inc.
RVNC
|
$2.18M |
| 4 |
TSVT
2seventy bio
TSVT
|
$1.87M |
| 5 |
Embecta
EMBC
|
$1.71M |
Top Sells
| 1 |
AdaptHealth
AHCO
|
$3.44M |
| 2 |
Elanco Animal Health
ELAN
|
$2.97M |
| 3 |
Centene
CNC
|
$2.7M |
| 4 |
iShares MBS ETF
MBB
|
$2.05M |
| 5 |
Lantheus
LNTH
|
$1.93M |
Sector Composition
| 1 | Healthcare | 61.76% |
| 2 | Real Estate | 10.3% |
| 3 | Financials | 3.56% |
| 4 | Technology | 3.07% |
| 5 | Energy | 2.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Viking Therapeutics
VKTX
$3.04B
| $664K | 0.38% |
+60,000
| New | +$664K |
|
77
iRhythm Technologies
IRTC
$5.46B
| $660K | 0.37% |
+7,000
| New | +$660K |
|
78
Exelixis
EXEL
$10.1B
| $656K | 0.37% |
30,000
-3,000
| -9% | -$65.6K |
|
79
Gilead Sciences
GILD
$140B
| $637K | 0.36% |
8,500
| – | – |
|
80
Zebra Technologies
ZBRA
$16.1B
| $591K | 0.34% |
+2,500
| New | +$591K |
|
81
JPMorgan BetaBuilders Japan ETF
BBJP
$13.8B
| $551K | 0.31% |
10,975
-414
| -4% | -$20.8K |
|
82
Nuvation Bio
NUVB
$1.02B
| $549K | 0.31% |
410,000
+65,000
| +19% | +$87.1K |
|
|
NNDM
83
Nano Dimension
NNDM
$300M
| $544K | 0.31% |
200,000
-50,000
| -20% | -$136K |
|
84
Globus Medical
GMED
$8.27B
| $497K | 0.28% |
+10,000
| New | +$497K |
|
85
Viatris
VTRS
$12.3B
| $468K | 0.27% |
47,500
-7,500
| -14% | -$74K |
|
|
PNT
86
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $450K | 0.26% |
67,400
-2,600
| -4% | -$17.3K |
|
87
Cigna
CI
$80.3B
| $435K | 0.25% |
1,519
-112
| -7% | -$32K |
|
88
Cardinal Health
CAH
$35.5B
| $420K | 0.24% |
4,835
-382
| -7% | -$33.2K |
|
89
Ventyx Biosciences
VTYX
$171M
| $417K | 0.24% |
+12,000
| New | +$417K |
|
90
FiscalNote
NOTE
$73.2M
| $416K | 0.24% |
200,000
| – | – |
|
91
Celldex Therapeutics
CLDX
$1.47B
| $413K | 0.23% |
15,000
| – | – |
|
92
Roivant Sciences
ROIV
$8.15B
| $409K | 0.23% |
+35,000
| New | +$409K |
|
93
Akero Therapeutics
AKRO
$3.74B
| $405K | 0.23% |
+8,000
| New | +$405K |
|
94
Invesco Senior Loan ETF
BKLN
$6.97B
| $404K | 0.23% |
19,258
-228
| -1% | -$4.79K |
|
95
SoundHound AI
SOUN
$5.31B
| $402K | 0.23% |
200,000
| – | – |
|
96
iShares JPMorgan EM High Yield Bond ETF
EMHY
$494M
| $398K | 0.23% |
11,696
-168
| -1% | -$5.72K |
|
97
McKesson
MCK
$85.4B
| $397K | 0.23% |
913
-52
| -5% | -$22.6K |
|
98
SPDR Bloomberg Convertible Securities ETF
CWB
$4.41B
| $396K | 0.22% |
5,834
-180
| -3% | -$12.2K |
|
99
Invesco S&P 500 BuyWrite ETF
PBP
$290M
| $393K | 0.22% |
18,437
-101
| -0.5% | -$2.16K |
|
100
SPDR S&P International Dividend ETF
DWX
$489M
| $389K | 0.22% |
11,824
+42
| +0.4% | +$1.38K |
|